COVID-19 virus’s weekly COVID-19 news round-up

pharmafile | April 7, 2021 | News story | Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news 

The past week has seen plenty of COVID-19 vaccine news; AstraZeneca has halted the paediatric trial of their jab amid fear over blood clots, while Valneva’s new vaccine candidate advances to a Phase III trial, and the Pfizer-BioNTech shot has proven to remain 91.3% effective after six months.

1. AstraZeneca halt paediatric trial of COVID-19 vaccine amid blood clot probe – Published 07/04/2021

AstraZeneca has halted the trial of its COVID-19 vaccine on children aged between 6 and 17, while regulators investigate a possible link with the vaccine to rare blood-clot events in adults.

2. Valneva’s inactivated COVID-19 vaccine candidate advances to Phase III trial – Published 06/04/21

Specialty vaccine company Valneva’s inactivated COVID-19 jab has shown positive results in a Phase I/II trial, with a seroconversion rate of 100% in participants that received a high dose.

3. Pfizer vaccine 91.3% effective after six months, Phase III study shows – Published 06/04/21

Pfizer and BioNTech’s follow-up study of their COVID-19 vaccine has confirmed the jab’s high efficacy after up to six months, with an effectiveness of 91.3% against the virus.

4. BD’s rapid COVID-19 test granted Emergency Use Authorization by FDA – Published – 01/04/21

The FDA has granted Emergency Use Authorization (EUA) for Becton, Dickinson and Company’s (BD) rapid antigen test to be used for COVID-19 screening of asymptomatic individuals.

5. Celonic to manufacture at least 100 million CureVac COVID-19 jabs – Published 31/03/21

Celonic are to manufacture more than 100 million doses of CureVac’s COVID-19 vaccine, with 50 million shots expected to be produced before the end of this year.

Jack Goddard

Related Content

FDA approves first oral antiviral to treat adult patients with COVID-19

The US Food and Drug Administration (FDA) has announced that it has approved the oral …


Moderna and Pfizer COVID-19 vaccine protection declines over time

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on …

Sanofi complete acquisition of mRNA company Translate Bio

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal …

Latest content